Postdoctoral Positions in Growth Factor Receptor Signaling and Physiology: NUS, Singapore and KI, Sweden

We are seeking talented and enthusiastic researchers with expertise in cell signaling, cell biology and mouse genetics to advance investigations on the functions and mechanisms of growth factor receptor signaling and physiology. The research entails studies of different receptor systems, including death receptor p75NTR, TGFbeta superfamily receptor ALK7 and neurotrophin receptor TrkB, using molecular methods, cell culture models and mutant mice carrying specific mutations in these receptors. Please refer to our recent list of publications in this areas.

Candidates will be accepted at the postdoctoral level with a PhD awarded preferably within the last 5 years. Strong and documented expertise in cellular, molecular and histological methods as applied to studies of mouse models in the areas of either neurobiology, metabolic regulation or cancer is a requirement for consideration. The successful candidate is expected to be sufficiently independent to formulate questions, design experiments and perform research.

We are recruiting fellows for our laboratories at the National University of Singapore and the Karolinska Institute in Stockholm, Sweden. Interested applicants can apply to both locations or just one. Work at the two laboratories is seamlessly integrated through joint lab meetings, common reagent and protocol records, and other cloud-based tools. Both sites provide exciting environments to pursue biomedical research at the highest level and a great opportunity to advance a career in science in exciting locations in Europe and Asia.

Applications, including CV, list of publications and statement of research interests should be sent to Prof. Carlos Ibanez ( or ). Applicants should arrange to have at least two confidential letters of reference sent independently by referees to either email address.

Applications will be considered as they arrive until the positions are filled. Interested applicants are strongly recommended to submit their applications as soon as possible. Funding is available for an initial period of 3 to 4 years, starting any time during 2018 or early 2019.

Featured article

Convergence of TDP-43 and BDNF signaling hubs

Articles by topic